Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome

NCT02156674 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Maroteaux-Lamy Syndrome

Interventions

DRUG: Naglazyme®

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]